Howard Hughes Medical Institute’s Marvell Technology MRVL Stock Holding History

Howard Hughes Medical Institute’s Portfolio MRVL Stock Details MRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-43,488	Closed	-$573K	–	173
2015 Q2	$573K	Sell	43,488 -73,783	-63%	-$1.06M	0.12%	96
2015 Q1	$1.72M	Buy	117,271 +15,923	+16%	+$252K	0.23%	57
2014 Q4	$1.47M	Buy	101,348 +3,655	+4%	+$49.6K	0.39%	54
2014 Q3	$1.32M	Buy	97,693 +46,270	+90%	+$637K	0.29%	46
2014 Q2	$737K	Buy	51,423 +23	+0%	+$354	0.12%	46
2014 Q1	$810K	Sell	51,400 -9,008	-15%	-$138K	0.12%	45
2013 Q4	$869K	Buy	60,408 +4,269	+8%	+$55K	0.13%	43
2013 Q3	$646K	Buy	56,139 +3,059	+6%	+$37.7K	0.1%	46
2013 Q2	$622K	Buy	+53,080	New	+$576K	0.2%	51

Other funds holding MRVL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Howard Hughes Medical Institute's MRVL Position: Q3 2015 in Review

Howard Hughes Medical Institute sold out of Marvell Technology (MRVL) in Q3 2015, closing a stake of 43,488 shares — an estimated $573K sold.

Howard Hughes Medical Institute first reported a position in MRVL in Q2 2013 and held it in 9 quarters. The position peaked at $1.72M in Q1 2015. 260 funds tracked by Wall St. Rank hold MRVL as of Q3 2015.

Howard Hughes Medical Institute reported no remaining Marvell Technology position as of Q3 2015 after selling out during the quarter.
Howard Hughes Medical Institute sold 43,488 Marvell Technology shares in Q3 2015, an estimated $573K.
Howard Hughes Medical Institute first reported a position in Marvell Technology in Q2 2013 and held it in 9 quarters.
Howard Hughes Medical Institute's Marvell Technology position peaked at $1.72M in Q1 2015.
260 funds tracked by Wall St. Rank held Marvell Technology as of Q3 2015.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2015, filed 16 Nov 2015.